Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice

Leukemia

Volumn 21, Issue 1, 2007, Pages 136-142

  Ninomiya, M ^a   Abe, A ^a   Katsumi, A ^a   Xu, J ^a   Ito, M ^b,d   Arai, F ^c   Suda, T ^c   Kiyoi, H ^e   Kinoshita, T ^a   Naoe, T ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^e NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; MICROSOMAL AMINOPEPTIDASE; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER TRANSPLANTATION; CELL COMPOSITION; CELL CONTACT; CELL COUNT; CELL LABELING; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIAPHYSIS; DISEASE MODEL; DRUG MEGADOSE; EPIPHYSIS; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IN VIVO STUDY; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SCID MOUSE; TRABECULAR BONE; UMBILICAL CORD BLOOD; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

EID: 33845540617     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404432     Document Type: Article

References (38)

1. Whetton AD, Graham GJ. Homing and mobilization in the stem cell niche. Trends Cell Biol 1999; 9: 233-238.
2. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625-637.
3. Yoshimoto M, Shinohara T, Heike T, Shiota M, Kanatsu-Shinohara M, Nakahata T. Direct visualization of transplanted hematopoietic cell reconstitution in intact mouse organs indicates the presence of a niche. Exp Hematol 2003; 31: 733-740.
4. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841.
5. Zhu J, Emerson SG. A new bone to pick: Osteoblasts and the haematopoietic stem-cell niche. Bioessays 2004; 26: 595-599.
6. - cells and SCID-repopulating cells. Blood 2005; 105: 576-583.
7. Balduino A, Hurtado SP, Frazao P, Takiya CM, Alves LM, Nasciutti LE et al. Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations. Cell Tissue Res 2005; 319: 255-266.
8. Mendes SC, Robin C, Dzierzak E. Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny. Development 2005; 132: 1127-1136.
9. Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006; 116: 1195-1201.
10. Nilsson SK, Hulspas R, Weier HU, Quesenberry PJ. In situ detection of individual transplanted bone marrow cells using FISH on sections of paraffin-embedded whole murine femurs. J Histochem Cytochem 1996; 44: 1069-1074.
11. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: Inferences for the localization of stem cell niches. Blood 2001; 97: 2293-2299.
12. Haylock DN, Nilsson SK. Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle 2005; 4: 1353-1355.
13. Taichman RS. Blood and bone: Two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 2005; 105: 2631-2639.
14. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005; 106: 1232-1239.
15. Suda T, Arai F, Hirao A. Hematopoietic stem cells and their niche. Trends Immunol 2005; 26: 426-433.
16. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-846.
17. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K et al. Tie2/ angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-161.
18. Taussig DC, Pearce DJ, Simpson C, Rohatiner AZ, Lister TA, Kelly G et al. Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 2005; 106: 4086-4092.
19. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737.
20. Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004; 5: 738-743.
21. Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 2000; 14: 1777-1784.
22. Bonnet D. Haematopoietic stem cells. J Pathol 2002; 197: 430-440.
23. -: Which is the more primitive? Leukemia 2002; 16: 1603-1608.
24. Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA 2001; 98: 10857-10862.
25. Tavor S, Petit I, Porozov S, Avigdor A, Dar A, Leider-Trejo L et al. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 2004; 64: 2817-2824.
26. null mouse: An excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175-3182.
27. Xu J, Nagata K, Obata K, Ichihara S, Izawa H, Noda A et al. Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats. Hypertension 2005; 46: 719-724.
28. null mice model. Blood 2003; 102: 873-880.
29. + cells. Exp Hematol 2003; 31: 789-797.
30. null mice. Mol Ther 2004; 10: 882-891.
31. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595-599.
32. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283: 845-848.
33. Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005; 6: 1038-1046.
34. Fragoso R, Pereira T, Wu Y, Zhu Z, Cabecadas J, Dias S. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood 2006; 107: 1608-1616.
35. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820-827.
36. Baumheter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD et al. Binding of L-selectin to the vascular sialomucin CD34. Science 1993; 262: 436-438.
37. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 1994; 84: 2554-2565.
38. Puri KD, Finger EB, Gaudernack G, Springer TA. Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. J Cell Biol 1995; 131: 261-270.